Navigation Links
Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
Date:11/8/2010

GERMANTOWN, Md., Nov. 8, 2010 /PRNewswire-USNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced that Tim Goodnow, Ph.D., will be joining the Board of Directors and working with the Company as a Consultant.

Dr. Goodnow was most recently with Abbott Diabetes Care where he was the Vice President, Technical Operations.  Prior to that, he held positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare.  Dr. Goodnow has led the successful development of a number of FDA approved glucose monitoring systems.  He holds a Ph.D. and B.S. in Chemistry from the University of Miami.

"I am thrilled to be joining the Sensors for Medicine and Science Board of Directors," said Dr. Goodnow.  "I look forward to working with the team to successfully launch these innovative new devices and am excited about the improvements they can make for people with diabetes."

"Tim is a great addition to our Board," stated Stephen P. DeFalco, Executive Chairman.  "His experience and track record bringing innovative glucose monitoring devices to market will help accelerate our efforts."

Sensors for Medicine and Science's lead product is a long-term, implanted continuous glucose monitor based on its unique and proprietary sensor technology.  This product includes a miniaturized sensor and an external reader.  The sensor is inductively powered and remotely interrogated, so there is no battery on-board and no wires connecting the implanted sensor to the external reader.  As a result, after implantation, the sensor functions noninvasively, painlessly, automatically, and continuously.  The Company is also developing a version of the technology to support efforts for glycemic control of patients in an Intensive Care Unit setting.

About Sensors for Medicine and Science, Inc.

Sensors for Medicine and Science, Inc. is pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes.  The Company believes that its long-term, continuous glucose monitor technology has the potential to replace regular finger stick monitoring.  

Sensors for Medicine and Science, Inc. has also developed oxygen sensor technology, with potential applications in areas such as metabolic monitoring (weight management), respiratory and cardiac disease.  In addition, the Company sells its oxygen sensors as a component to original equipment manufacturers.

For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.


'/>"/>
SOURCE Sensors for Medicine and Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
2. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
3. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
4. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
5. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
6. CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
7. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
8. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
9. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... oxygen therapy devices market to grow at a CAGR of 10.16% ... Therapy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/23/2017)... A research report by Mordor Intelligence ... reach USD 7.2 billion by the end of 2021 and ... procedure in which a sample is preserved prior to its ... since the methods are often allowing repeated testing. The report ... shared procedures in the lab. In many life science labs, ...
(Date:3/23/2017)... BOSTON , March 23, 2017 ... respond optimally to most vaccines because their young ... researchers at Boston Children,s Hospital report achieving strong ... the final preclinical model before human trials — ... the immune response. In two simultaneous papers, they ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/23/2017)... Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... emergency and now estimates that there could be four million Zika-related cases in the ... to date with numbers of US cases reported per year skyrocketing to an estimated ...
(Date:3/23/2017)... Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... new clinic, located at 960 Gruene Road in Building 2. The clinic is the ... Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things ...
(Date:3/23/2017)... ... ... are unaware of the dangers that infectious bacteria play in mouth disease, while 1 out ... that dentists recommend. The ramifications of improper oral upkeep go far beyond bad breath and ... hours of work each year due to dental issues. That is why Mediaplanet is proud ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
Breaking Medicine News(10 mins):